Concert Pharmaceuticals, Inc. Operating Lease Right-of-Use Assets
Concert Pharmaceuticals, Inc. had Operating Lease Right-of-Use Assets of $8.21 million as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2022-11-07
- 2022-09-30: Operating Lease, Right-of-Use Asset $8.21M.
- 2022-06-30: Operating Lease, Right-of-Use Asset $8.34M.
- 2022-03-31: Operating Lease, Right-of-Use Asset $8.47M.
- 2021-12-31: Operating Lease, Right-of-Use Asset $8.59M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2022-09-30 | $8.21M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $8.34M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $8.47M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $8.59M 10-Q · filed 2022-11-07 |
| 2021-09-30 | $8.69M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $8.79M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $8.88M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $8.97M 10-K · filed 2022-03-03 |
| 2020-09-30 | $9.05M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.12M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $9.18M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $9.25M 10-K · filed 2021-02-25 |
| 2019-09-30 | $9.32M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $9.38M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $9.43M 10-Q · filed 2019-05-02 |
| 2019-01-01 | $9.50M 10-Q · filed 2022-11-07 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-07 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-01 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 |